0001181431-11-050247.txt : 20110922 0001181431-11-050247.hdr.sgml : 20110922 20110922171541 ACCESSION NUMBER: 0001181431-11-050247 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110920 FILED AS OF DATE: 20110922 DATE AS OF CHANGE: 20110922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrlich Christopher B CENTRAL INDEX KEY: 0001293973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51967 FILM NUMBER: 111103695 MAIL ADDRESS: STREET 1: C/O INTERWEST PARTNERS STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 rrd322433.xml INTERWEST/ EHRLICH PURCHASE X0304 4 2011-09-20 0 0001178711 Transcept Pharmaceuticals Inc TSPT 0001293973 Ehrlich Christopher B C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD, SUITE 110 POINT RICHMOND CA 94804 1 0 1 0 Common Stock 2011-09-20 4 P 0 514848 6.585 A 1766656 I See footnote Common Stock 2011-09-21 4 P 0 217228 7.2418 A 1983884 I See footnote The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $5.64 to $7.00 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. The reported securities are owned directly by InterWest Partners IX, L.P. ("the LP") and may be deemed to be beneficially owned indirectly by InterWest Management Partners IX, LLC ("the LLC"), as general partner of the LP. The reporting person as a venture member of the LLC disclaims any beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The purchase price reported in column 4 of Table 1 represents the weighted average purchase price of the shares purchased ranging from $6.96 to $7.50 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. /s/ Marilyn E. Wortzman, by power of attorney 2011-09-22